C - Chemistry – Metallurgy – 07 – K
Patent
C - Chemistry, Metallurgy
07
K
C07K 14/715 (2006.01) G01N 33/566 (2006.01) A61K 38/00 (2006.01)
Patent
CA 2093145
The invention relates to substantially pure interleukin-9 receptor molecules, and the uses thereof. The molecule is a glycoprotein of about 64 kilodaltons and, upon digestion with N-glycosidase F, yields a peptide of about 54 kilodaltons. Figure 2 shows the binding of radioactive IL-9 to TS1 cells; which contain the IL-9 receptor, over time at various incubation temperatures. The substantially purified molecule can be used to inhibit the effect of IL-9 on an individual, to determine the amount of IL-9 in a sample, to determine the presence of cells which contain the IL-9 receptor, and to screen pharmaceuticals far efficacy in treating conditions characterized by excess proliferation of cells which proliferate in response to IL-9.
Coulie Pierre
Druez Catherine
Uyttenhove Catherine
Van Snick Jacques
Ludwig Institute For Cancer Research
Norton Rose Or S.e.n.c.r.l. S.r.l./llp
LandOfFree
Substantially pure interleukin-9 receptor and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substantially pure interleukin-9 receptor and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substantially pure interleukin-9 receptor and uses thereof will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2022256